The role of exosomes in tumor progression and metastasis (Review)

Oncology Reports

Volumn 35, Issue 3, 2016, Pages 1237-1244

  Suchorska, Wiktoria M ^a,c   Lach, Michal S ^a,b  

^a GREATER POLAND CANCER CENTRE   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Epithelialmesenchymal transition; Extracellular vesicles; Immune escape; Multidrug resistance; Radiation induced bystander effect; Radioresistance

Indexed keywords

APOPTOSIS; BYSTANDER EFFECT; CANCER RESISTANCE; CELL COMMUNICATION; CELL POPULATION; EXOSOME; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REVIEW; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; NEOPLASM; PATHOLOGY; PROGNOSIS;

MESSENGER RNA; MICRORNA;

EPITHELIAL-MESENCHYMAL TRANSITION; EXOSOMES; EXTRACELLULAR VESICLES; HUMANS; MICRORNAS; NEOPLASMS; PROGNOSIS; RNA, MESSENGER; TUMOR MICROENVIRONMENT;

EID: 84955492309     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4507     Document Type: Review

References (82)

1. Trams EG, Lauter CJ, Salem N Jr and Heine U: Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 645: 63-70, 1981.
2. Johnstone RM, Adam M, Hammond JR, Orr L and Turbide C: Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262: 9412-9420, 1987.
3. Oosthuyzen W, Sime NEL, Ivy JR, Turtle EJ, Street JM, Pound J, Bath LE, Webb DJ, Gregory CD, Bailey MA, et al: Quantification of human urinary exosomes by nanoparticle tracking analysis. J Physiol 591: 5833-5842, 2013.
4. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RT, Webb DJ and Dear JW: Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 10: 5, 2012.
5. Lasser C, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A, Sjostrand M, Gabrielsson S, Lotvall J and Valadi H: Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J Transl Med 9: 9, 2011.
6. Thery C: Exosomes: Secreted vesicles and intercellular communications. F1000 Biol Rep 3: 15, 2011.
7. Umezu T, Ohyashiki K, Kuroda M and Ohyashiki JH: Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32: 2747-2755, 2013.
8. Vlassov AV, Magdaleno S, Setterquist R and Conrad R: Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820: 940-948, 2012.
9. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, Schiffelers RM, Gucek M and van Balkom BW: Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 1: 18396, 2012.
10. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringner M, Morgelin M, Bourseau-Guilmain E, Bengzon J and Belting M: Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci USA 110: 7312-7317, 2013.
11. Arscott WT, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, Zhang G, Tofilon PJ and Camphausen KA: Ionizing radiation and glioblastoma exosomes: Implications in tumor biology and cell migration. Transl Oncol 6: 638-648, 2013.
12. Maheshwari S, Singh AK, Arya RK, Pandey D, Singh A and Datta D: Exosomes: Emerging players of intercellular communication in tumor microenvironment. Disoveries 2: e26, 2014.
13. van Dommelen SM, Vader P, Lakhal S, Kooijmans SA, van Solinge WW, Wood MJ and Schiffelers RM: Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 161: 635-644, 2012.
14. Taylor DD and Gercel-Taylor C: The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet 4: 142, 2013.
15. Kharaziha P, Ceder S, Li Q and Panaretakis T: Tumor cell-derived exosomes: A message in a bottle. Biochim Biophys Acta 1826: 103-111, 2012.
16. Escrevente C, Grammel N, Kandzia S, Zeiser J, Tranfield EM, Conradt HS and Costa J: Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells. PLoS One 8: e78631, 2013.
17. Rappa G, Mercapide J, Anzanello F, Pope RM and Lorico A: Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol Cancer 12: 62, 2013.
18. van den Boorn JG, Dassler J, Coch C, Schlee M and Hartmann G: Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 65: 331-335, 2013.
19. Gross JC, Chaudhary V, Bartscherer K and Boutros M: Active Wnt proteins are secreted on exosomes. Nat Cell Biol 14: 1036.1045, 2012.
20. U rbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, Tancini B and Emiliani C: Signaling pathways in exosome biogenesis, secretion and fate. Genes 4: 152-170, 2013.
21. Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M and Thery C: Rab27a supports exosome-dependent and-independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 72: 4920-4930, 2012.
22. Raposo G and Stoorvogel W: Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373-383, 2013.
23. Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, Yasar S and Dworacki G: Exosomes-structure, biogenesis and biological role in non-small-cell lung cancer. Scand J Immunol 81: 2-10, 2015.
24. Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, Blot B, Haase G, Goldberg Y and Sadoul R: Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 46: 409-418, 2011.
25. Stoorvogel W, Kleijmeer MJ, Geuze HJ and Raposo G: The biogenesis and functions of exosomes. Traffic 3: 321-330, 2002.
26. Friel AM, Corcoran C, Crown J and O Driscoll L: Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. Breast Cancer Res Treat 123: 613-625, 2010.
27. Vaksman O, Trope C, Davidson B and Reich R: Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis 35: 2113-2120, 2014.
28. Zhang HG and Grizzle WE: Exosomes: A novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions. Am J Pathol 184: 28-41, 2014.
29. Nikitina IG, Sabirova EIu, Karpov VL, Lisitsyn NA and Beresten' SF: The role of exosomes and microvesicles in carcinogenesis. Mol Biol 47: 767-773, 2013 (In Russian).
30. Martin BJ: Inhibiting vasculogenesis after radiation: A new paradigm to improve local control by radiotherapy. Semin Radiat Oncol 23: 281-287, 2013.
31. Roos WP and Kaina B: DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332: 237-248, 2013.
32. K han S, Jutzy JMS, Aspe JR, McGregor DW, Neidigh JW and Wall NR: Survivin is released from cancer cells via exosomes. Apoptosis 16: 1-12, 2011.
33. Jalal N, Haq S, Anwar N, Nazeer S and Saeed U: Radiation induced bystander effect and DNA damage. J Cancer Res Ther 10: 819-833, 2014.
34. Sokolov MV and Neumann RD: Radiation-induced bystander effects in cultured human stem cells. PLoS One 5: e14195, 2010.
35. Mothersill C and Seymour CB: Radiation-induced bystander effects-implications for cancer. Nat Rev Cancer 4: 158-164, 2004.
36. Cheng L, Sharples RA, Scicluna BJ and Hill AF: Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3: 3, 2014.
37. Al-Mayah AHJ, Irons SL, Pink RC, Carter DRF and Kadhim MA: Possible role of exosomes containing RNA in mediating nontargeted effect of ionizing radiation. Radiat Res 177: 539-545, 2012.
38. Hummel R, Hussey DJ and Haier J: MicroRNAs: Predictors and modifiers of chemo-and radiotherapy in different tumour types. Eur J Cancer 46: 298-311, 2010.
39. Jella KK , Rani S, O Driscoll L, McClean B, Byrne HJ and Lyng FM: Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells. Radiat Res 181: 138-145, 2014.
40. Savina A, Furlán M, Vidal M and Colombo MI: Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278: 20083-20090, 2003.
41. Rubis̈ B, Hołysz H, Barczak W, Gryczka R, Łaciński M, Jagielski P, Czernikiewicz A, Półrolniczak A, Wojewoda A, Perz K , et al: Study of ABCB1 polymorphism frequency in breast cancer patients from Poland. Pharmacol Rep 64: 1560-1566, 2012.
42. Eckford PDW and Sharom FJ: ABC efflux pump-based resistance to chemotherapy drugs. Chem Rev 109: 2989-3011, 2009.
43. Rodriguez-Antona C and Ingelman-Sundberg M: Cytochrome P450 pharmacogenetics and cancer. Oncogene 25: 1679-1691, 2006.
44. Rebucci M and Michiels C: Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 85: 1219-1226, 2013.
45. Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, et al: Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 96: 1702-1713, 2004.
46. Safaei R, Larson BJ, Cheng TC, Gibson MA, Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4: 1595-1604, 2005.
47. Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Della Mina P, Menard S, et al: Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 227: 658-667, 2012.
48. X iao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu Y and Feng J: Exosomes: Decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS One 9: e89534, 2014.
49. Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, et al: Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One 9: e95240, 2014.
50. Vella LJ: The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol 4: 361, 2014.
51. Nishikata T, Ishikawa M, Matsuyama T, Takamatsu K, Fukuhara T and Konishi Y: Primary culture of breast cancer: A model system for epithelial-mesenchymal transition and cancer stem cells. Anticancer Res 33: 2867-2873, 2013.
52. Qureshi R, Arora H and Rizvi MA: EMT in cervical cancer: Its role in tumour progression and response to therapy. Cancer Lett 356: 321-331, 2015.
53. Davidson B, Tropé CG and Reich R: Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol 2: 33, 2012.
54. Gou WF, Zhao Y, Lu H, Yang XF, Xiu YL, Zhao S, Liu JM, Zhu ZT, Sun HZ, Liu YP, et al: The role of RhoC in epithelialto-mesenchymal transition of ovarian carcinoma cells. BMC Cancer 14: 477, 2014.
55. Geng SQ, Alexandrou AT and Li JJ: Breast cancer stem cells: Multiple capacities in tumor metastasis. Cancer Lett 349: 1-7, 2014.
56. Shimoda M and Khokha R: Proteolytic factors in exosomes. Proteomics 13: 1624-1636, 2013.
57. Tauro BJ, Mathias RA, Greening DW, Gopal SK, Ji H, Kapp EA, Coleman BM, Hill AF, Kusebauch U, Hallows JL, et al: Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelialmesenchymal transition. Mol Cell Proteomics 12: 2148-2159, 2013.
58. Webber J, Steadman R, Mason MD, Tabi Z and Clayton A: Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70: 9621-9630, 2010.
59. Borges FT, Melo SA, Özdemir BC, Kato N, Revuelta I, Miller CA, Gattone VH II, LeBleu VS and Kalluri R: TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol 24: 385-392, 2013.
60. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M and Wrana JL: Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151: 1542-1556, 2012.
61. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L, Hancox RA, Fletcher A and Saldanha GS: WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 14: 5825-5832, 2008.
62. Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T and Leandersson K: WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer 13: 88, 2014.
63. McCready J, Sims JD, Chan D and Jay DG: Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: A role for plasminogen activation. BMC Cancer 10: 294, 2010.
64. Hendrix A, Westbroek W, Bracke M and De Wever O: An ex(o) citing machinery for invasive tumor growth. Cancer Res 70: 9533-9537, 2010.
65. Kucharzewska P and Belting M: Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles 2: 20304, 2013.
66. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B and Camussi G: Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71: 5346-5356, 2011.
67. Diaz-Cano SJ: Tumor heterogeneity: Mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci 13: 1951-2011, 2012.
68. De Palma M and Hanahan D: The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities. Mol Oncol 6: 111-127, 2012.
69. Igney FH and Krammer PH: Immune escape of tumors: Apoptosis resistance and tumor counterattack. J Leukoc Biol 71: 907-920, 2002.
70. K im R, Emi M and Tanabe K: Cancer immunoediting from immune surveillance to immune escape. Immunology 121: 1-14, 2007.
71. Whiteside TL, Mandapathil M, Szczepanski M and Szajnik M: Mechanisms of tumor escape from the immune system: Adenosine-producing Treg, exosomes and tumor-associated TLRs. Bull Cancer 98: E25-E31, 2011.
72. Mandapathil M, Lang S, Gorelik E and Whiteside TL: Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 346: 55-63, 2009.
73. Mandapathil M, Hilldorfer B, Szczepanski MJ, Czystowska M, Szajnik M, Ren J, Lang S, Jackson EK, Gorelik E and Whiteside TL: Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J Biol Chem 285: 7176-7186, 2010.
74. Clayton A, Al-Taei S, Webber J, Mason MD and Tabi Z: Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 187: 676-683, 2011.
75. Pardali K and Moustakas A: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775: 21-62, 2007.
76. Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL and Boyiadzis M: Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factorbeta1. Haematologica 96: 1302-1309, 2011.
77. Mincheva-Nilsson L and Baranov V: Cancer exosomes and NKG2D receptor-ligand interactions: Impairing NKG2Dmediated cytotoxicity and anti-tumour immune surveillance. Semin Cancer Biol 28: 24-30, 2014.
78. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M and Whiteside TL: Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 5: e11469, 2010.
79. Whiteside TL: What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol 22: 327-334, 2012.
80. Stenqvist AC, Nagaeva O, Baranov V and Mincheva-Nilsson L: Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol 191: 5515-5523, 2013.
81. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL and Min WP: Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 35: 169-173, 2005.
82. Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, Zeidler R, Lang S and Whiteside TL: Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck 31: 371-380, 2009.